[Melanoma at a dysplastic nevus excision site in a patient on etanercept].
Hacard
F
F
Bens
G
G
Maitre
F
F
Le Bidre
E
E
Estève
E
E
D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002921:Cicatrix / Q000473:pathology; D004416:Dysplastic Nevus Syndrome / Q000473:pathology / Q000601:surgery*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008545:Melanoma / Q000473:pathology*; D018124:Receptors, Tumor Necrosis Factor; D012878:Skin Neoplasms / Q000473:pathology*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept
Mélanome sur site d'exérèse d'un naevus dysplasique au cours d'un traitement par étanercept.